ClearNote Health

ClearNote Health (formerly Bluestar Genomics) is a cancer detection company focused on helping individuals at high risk for deadly cancers live longer and healthier lives. Using a standard blood draw, the company leverages its proprietary epigenomic platform, combining biology and artificial intelligence, to identify DNA-based biological changes during cancer development. ClearNote Health is a leader in the non-invasive early detection of pancreatic and ovarian cancers in high-risk patients, identifying cancer before it progresses and at a stage when patients are most likely to benefit from treatment.